The global market for Lacrimal Duct Stent Tubes was estimated at US$41.1 Million in 2024 and is projected to reach US$46.5 Million by 2030, growing at a CAGR of 2.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Lacrimal Duct Stent Tubes market.
The design and manufacturing of lacrimal duct stent tubes have seen significant advancements over the years. Modern stent tubes are more effective and comfortable for patients, incorporating features that reduce the risk of infection and increase the longevity of the device`s functionality. Recent developments include the use of drug-eluting stents, which slowly release medications to prevent inflammation or infection directly at the site of implantation. Additionally, improvements in the imaging technologies used during insertion procedures, such as endoscopic techniques, have enhanced the precision and safety of the surgery, leading to better outcomes and shorter recovery times for patients. These technological advancements not only improve patient comfort and procedure success rates but also contribute to the overall efficiency of treatments for tear duct obstructions.
The growth in the lacrimal duct stent tubes market is driven by several factors, including increasing prevalence of lacrimal system disorders, technological advancements in stent design and surgery, and a growing preference for minimally invasive surgical procedures. As populations age, the incidence of conditions like dry eye and other tear duct abnormalities increases, creating a higher demand for effective treatment solutions such as stenting. Technological innovations that enhance the safety and efficacy of lacrimal duct surgeries and stent implementations are key to this market’s expansion. Additionally, as consumer awareness of available treatment options grows, more patients are likely to opt for procedures that promise quicker recovery and fewer complications, such as those involving advanced stent tubes. Furthermore, improvements in healthcare infrastructure and increased healthcare spending globally enable greater access to such specialized medical treatments, supporting the growth of the lacrimal duct stent market. Together, these factors are propelling the adoption of lacrimal duct stents as a standard treatment for relevant ophthalmic conditions.
Global Lacrimal Duct Stent Tubes Market - Key Trends and Drivers Summarized
Lacrimal duct stent tubes are medical devices used to treat conditions related to the lacrimal system, which is responsible for the drainage of tears from the eye into the nasal cavity. These stent tubes are particularly used in cases where the natural tear ducts are blocked, causing excessive tearing and discomfort, a condition known as dacryocystitis. Lacrimal duct stent tubes help to restore the proper flow of tears by opening up the blocked ducts. The procedure for inserting these tubes, typically a minimally invasive surgery known as dacryocystorhinostomy, involves creating a new route for tears to pass from the lacrimal sac into the nose. The stents are usually made from silicone and are designed to be biocompatible and flexible, which minimizes the risk of irritation and allows them to be in place for extended periods if necessary.The design and manufacturing of lacrimal duct stent tubes have seen significant advancements over the years. Modern stent tubes are more effective and comfortable for patients, incorporating features that reduce the risk of infection and increase the longevity of the device`s functionality. Recent developments include the use of drug-eluting stents, which slowly release medications to prevent inflammation or infection directly at the site of implantation. Additionally, improvements in the imaging technologies used during insertion procedures, such as endoscopic techniques, have enhanced the precision and safety of the surgery, leading to better outcomes and shorter recovery times for patients. These technological advancements not only improve patient comfort and procedure success rates but also contribute to the overall efficiency of treatments for tear duct obstructions.
The growth in the lacrimal duct stent tubes market is driven by several factors, including increasing prevalence of lacrimal system disorders, technological advancements in stent design and surgery, and a growing preference for minimally invasive surgical procedures. As populations age, the incidence of conditions like dry eye and other tear duct abnormalities increases, creating a higher demand for effective treatment solutions such as stenting. Technological innovations that enhance the safety and efficacy of lacrimal duct surgeries and stent implementations are key to this market’s expansion. Additionally, as consumer awareness of available treatment options grows, more patients are likely to opt for procedures that promise quicker recovery and fewer complications, such as those involving advanced stent tubes. Furthermore, improvements in healthcare infrastructure and increased healthcare spending globally enable greater access to such specialized medical treatments, supporting the growth of the lacrimal duct stent market. Together, these factors are propelling the adoption of lacrimal duct stents as a standard treatment for relevant ophthalmic conditions.
SCOPE OF STUDY:
The report analyzes the Lacrimal Duct Stent Tubes market in terms of units by the following Segments, and Geographic Regions/Countries:- Segments: Tube Type (Bicanalicular Tubes, Monocanalicular Tubes); End-Use (Hospitals End-Use, Ophthalmic Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Bicanalicular Tubes segment, which is expected to reach US$35.0 Million by 2030 with a CAGR of a 2.3%. The Monocanalicular Tubes segment is also set to grow at 1.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $11.1 Million in 2024, and China, forecasted to grow at an impressive 4.4% CAGR to reach $9.1 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Lacrimal Duct Stent Tubes Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Lacrimal Duct Stent Tubes Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Lacrimal Duct Stent Tubes Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as BVI Medical, FCI Ophthalmics, Gunther Weiss Scientific Glassblowing Co., Inc., Kaneka Medical America LLC, Medline Industries, LP. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 46 companies featured in this Lacrimal Duct Stent Tubes market report include:
- BVI Medical
- FCI Ophthalmics
- Gunther Weiss Scientific Glassblowing Co., Inc.
- Kaneka Medical America LLC
- Medline Industries, LP.
- Surtex Instruments
- Walsh Medical Devices Inc.
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BVI Medical
- FCI Ophthalmics
- Gunther Weiss Scientific Glassblowing Co., Inc.
- Kaneka Medical America LLC
- Medline Industries, LP.
- Surtex Instruments
- Walsh Medical Devices Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 283 |
| Published | July 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 41.1 Million |
| Forecasted Market Value ( USD | $ 46.5 Million |
| Compound Annual Growth Rate | 2.1% |
| Regions Covered | Global |
